APO-ATOMOXETINE atomoxetine (as hydrochloride) 80 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-atomoxetine atomoxetine (as hydrochloride) 80 mg capsule blister pack

apotex pty ltd - atomoxetine hydrochloride -

APO-ATOMOXETINE atomoxetine (as hydrochloride) 18 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-atomoxetine atomoxetine (as hydrochloride) 18 mg capsule blister pack

apotex pty ltd - atomoxetine hydrochloride -

APO-ATOMOXETINE atomoxetine (as hydrochloride) 25 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-atomoxetine atomoxetine (as hydrochloride) 25 mg capsule blister pack

apotex pty ltd - atomoxetine hydrochloride -

APO-ATOMOXETINE atomoxetine (as hydrochloride) 100 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-atomoxetine atomoxetine (as hydrochloride) 100 mg capsule blister pack

apotex pty ltd - atomoxetine hydrochloride -

APO-ATOMOXETINE atomoxetine (as hydrochloride) 10 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-atomoxetine atomoxetine (as hydrochloride) 10 mg capsule blister pack

apotex pty ltd - atomoxetine hydrochloride -

APO-ATOMOXETINE atomoxetine (as hydrochloride) 60 mg capsule blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-atomoxetine atomoxetine (as hydrochloride) 60 mg capsule blister pack

apotex pty ltd - atomoxetine hydrochloride -

PEMAZYRE 13.5 MG Israel - English - Ministry of Health

pemazyre 13.5 mg

medison pharma ltd - pemigatinib - tablets - pemigatinib 13.5 mg - pemigatinib - pemazyre is a kinase inhibitor indicated for the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or other rearrangement as determined by a validated test.

PEMAZYRE 4.5 MG Israel - English - Ministry of Health

pemazyre 4.5 mg

medison pharma ltd - pemigatinib - tablets - pemigatinib 4.5 mg - pemigatinib - pemazyre is a kinase inhibitor indicated for the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or other rearrangement as determined by a validated test.

PEMAZYRE 9 MG Israel - English - Ministry of Health

pemazyre 9 mg

medison pharma ltd - pemigatinib - tablets - pemigatinib 9 mg - pemigatinib - pemazyre is a kinase inhibitor indicated for the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or other rearrangement as determined by a validated test.

POSTINOR-1 levonorgestrel 1.5mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

postinor-1 levonorgestrel 1.5mg tablet blister pack

gedeon richter australia pty ltd - levonorgestrel, quantity: 1.5 mg - tablet, uncoated - excipient ingredients: potato starch; maize starch; purified talc; lactose monohydrate; colloidal anhydrous silica; magnesium stearate - emergency contraception within 72 hours of unprotected intercourse.